Review Reports
- Laura Gilardi1,
- Lighea Simona Airò Farulla1,2 and
- Emre Demirci3
- et al.
Reviewer 1: Anonymous Reviewer 2: Anonymous
Round 1
Reviewer 1 Report
This is an interesting study reviewing recent developments on radiolabeled FAP inhibitors and their potential role in clinical practice. The manuscript is well-organized. In order to discuss the basic biological mechanisms, some pre-clinical animal research could be reviewed in added as a new subheading.
Author Response
Please see the attachment
Author Response File: 
Author Response.docx
Reviewer 2 Report
The author reviews the recent developments on radiolabeled FAP (fibroblast activation protein) inhibitors and the possible translation of this pan-tumoral approach in clinical practice. This paper shows a very well-organized work, the results from the available literature being comprehensively described. Therefore, I recommend its publication in Biomedicines.
Author Response
Please see the attachment
Author Response File: Author Response.docx